Necrotizing Pneumonia Among Italian Children in the Pneumococcal Conjugate Vaccine Era

Pneumonia

Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial

Vaccine.

Kilpi TM, Jokinen J, Puumalainen T, Nieminen H, Ruokokoski E, Rinta-Kokko H, Traskine M, Lommel P, Moreira M, Ruiz-Guinazu J, Borys D, Schuerman L, Palmu AA

doi: 10.1016/j.vaccine.

RECOMMENDED

Respiratory Tract Infection

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age

Vaccine.

Karppinen S, Toivonen L, Schuez-Havupalo L, Teros-Jaakkola T, Waris M, Auranen K, Palmu AA, Peltola V

doi: 10.1016/j.vaccine.2019.04.026.

Respiratory Tract Infection

Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study

PLoS One.

Domínguez Á, Ciruela P, Hernández S, García-García JJ, Soldevila N, Izquierdo C, Moraga-Llop F, Díaz A, F de Sevilla M, González-Peris S, Campins M, Uriona S, Martínez-Osorio J, Solé-Ribalta A, Codina G, Esteva C, Planes AM, Muñoz-Almagro C, Salleras L

doi: 10.1371/journal.

Further Publications

Invasive pneumococcal disease in children with sickle cell disease in the pneumococcal conjugate vaccine era

Pediatr Blood Cancer.

Martin OO, Moquist KL, Hennessy JM, Nelson SC

doi: 10.1002/pbc.26713.

PneumoniaRespiratory Tract Infection

Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine

Expert Rev Vaccines.

Wasserman M, Sings HL, Jones D, Pugh S, Moffatt M, Farkouh R

doi: 10.1080/

Pneumonia

Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study

Lancet Respir Med.

Savulescu C, Krizova P, Lepoutre A, Mereckiene J, Vestrheim DF, Ciruela P, Ordobas M, Guevara M, McDonald E, Morfeldt E, Kozakova J, Varon E, Cotter S, Winje BA, Munoz-Almagro C, Garcia L, Castilla J, Smith A, Henriques-Normark B, Celentano LP, Hanquet G; SpIDnet group.

doi: 10.1016/S2213-2600

Pneumonia

Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies

PLoS One.

Tin Tin Htar M, Stuurman AL, Ferreira G, Alicino C, Bollaerts K, Paganino C, Reinert RR, Schmitt HJ, Trucchi C, Vestraeten T, Ansaldi F

doi: 10.1371/

Pneumonia

Pneumococcal whole-cell and protein-based vaccines: changing the paradigm

Expert Rev Vaccines.

Pichichero ME

doi: 10.1080/

Pneumonia

Why is the rate of pneumococcal pneumonia declining?

Curr Opin Pulm Med.

Luna CM, Pulido L, Burgos D

doi: 10.1097/

Related content

Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age

Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study

Invasive pneumococcal disease in children with sickle cell disease in the pneumococcal conjugate vaccine era

Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine

Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study

Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies

Pneumococcal whole-cell and protein-based vaccines: changing the paradigm

Why is the rate of pneumococcal pneumonia declining?